Description
Estonia was selected to contribute as the first pilot country in creating Europe"s largest registry of cardiovascular diseases. The project will involve the development of a platform to help harmonise the collection of data related to cardiovascular diseases, increase the efficiency of analysing quality of care and support the execution of registry-based randomised cardiology trials. Lead by the Estonian Society of Cardiology, Estonia is taking part in the EuroHeart project initiated by the European Society of Cardiology. The project seeks to improve quality of care for patients with cardiovascular diseases. Cardiologists at Tartu University Hospital and North Estonia Medical Centre are participating in the EuroHeart project. EuroHeart annual report 2024 exposes details on patients with ST-elevation (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) and their characteristics, treatments with percutaneous coronary interventions(PCI), medications and in-hospital outcomes.Program launch date
By the end of 2024, fourteen countries have become members of the collaboration out of which eight participated in the registration of standardised data in 2023 which are included in this annual report.Responsible entity
European Society of Cardiology, Estonian Society of Cardiology,Available results and quality metrics
The hospitals reporting to EuroHeart cover the whole Estonia. According to the mandatory Estonian myocardial infarction registry the quality differences in the indicators reported in EuroHeart would not be large, but some variation exists. Altogether, data from 63,961 patients admitted with myocardial infarction from the eight countries are included to the EuroHeart project.Limitations / comments
National Registries of Estonia, France, Hungary, Iceland, Portugal, Romania, Singapore and Sweden are participating, and several more European countries will be included to the EuroHeart project.